ARTV

Artiva

--

--(--)

Market Open: --

--

--(--)

Post-Market: --

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

--

Prev.Close

--

%Range

--

Turnover

--

Avg Vol(4W)

--

Market Cap

--

Div.Yield

--

P/E(TTM)

--

EPS(TTM)

--

Beta

--

Free Float

--

Shares Outstanding

--

%Turnover

--

P/E(DYN)

--

P/B

--

BVPS

--

High

--

Low

--

52 Week High

--

52 Week Low

--

About ARTV

Artiva Biotherapeutics, Inc.

A clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies

Industry

Biological Technology

Established Date

02/14/2019

Listing Date

07/19/2024

Exchange

NASDAQ Stock Exchange

Full-time Employees

89

Fiscal Year Ends

12-31

Website

www.artivabio.com

Security Type

Common stock

Office address

5505 Morehouse Drive, Suite 100, San Diego, CA 92121

Business

--

Introduction

Artiva Biotherapeutics, Inc., was incorporated in Delaware on February 14, 2019. The company is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients with devastating autoimmune diseases and cancer.

Company Financials

EPS

ARTV has released its 2024 Q4 earnings. EPS was reported at -0.66, versus the expected -0.58, missing expectations. The chart below visualizes how ARTV has performed over recent quarters, highlighting trends in earnings surprises.